Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen Launches E-Gels Technology to Replace Electrophoresis


CARLSBAD, Calif.--Invitrogen announced the launch of E-Gels, a self-contained, bufferless, precast agarose gel, to make DNA electrophoresis easier and more convenient.

The technology provides forensic, military, environmental, and other researchers with a portable electrophoresis system that can be run outside of the laboratory, reducing the chance of error from contamination or time delays during sample transport. The company said E-Gels offer a more convenient and reproducible new way to perform high-resolution agarose gel electrophoresis.

Invitrogen develops technologies for gene cloning and expression, with applications for functional genomics studies in drug discovery, diagnostic testing, and crop improvement. Founded in 1987, the company is headquartered in San Diego and operates a European center with sales and distribution in Groningen, Netherlands.

Filed under

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.